Longstanding API Partner Gyma Laboratories has a 70-year track record as a trusted API supplier to the US pharmaceutical industry, indicating reliability and continuity that can support large-scale contract manufacturing and regulatory filings.

End-to-End CDMO Capabilities span from API development to finished dosage forms, dossier filing and launch, suggesting opportunities to engage across the full drug development lifecycle with potential for bundled programs.

Global Collaboration Positioned as a globally operating service provider, Gyma can support multinational pharmaceutical companies seeking consistent supply chains and international regulatory support, especially for US-market APIs.

Mid-Size Agility With 11-50 employees, Gyma combines flexibility with specialized expertise, presenting a fit for mid-sized biotech firms or niche programs that require hands-on attention and rapid collaboration.

Financial Footing Revenue in the likely range of 25 to 50 million signals a scalable operation capable of handling growing project scopes, potential for extended partnerships, and capability for increased manufacturing volumes.